Learning Objectives:

1. To understand the need for timely referral, assessment, pre-transplant optimization, and listing for potential lung transplant candidates.

2. To identify how a history of pre-transplant malignancy (both hematologic and solid organ) and cancer treatment impacts lung transplant candidacy and timing of transplant evaluation and listing.

3. To understand pre-lung transplant management of extrapulmonary manifestations of connective tissue diseases in the transplant candidate.

Session date: 
09/27/2021 - 4:00pm to 5:00pm CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Renea Jablonski, MD; Kevin Tsui, MD